Targeted Tumor Modulation

搜索文档
Bicara Therapeutics (BCAX) 2025 Conference Transcript
2025-09-03 23:57
Bicara Therapeutics (BCAX) 2025 Conference September 03, 2025 10:55 AM ET Company ParticipantsClaire Mazumdar - CEO & DirectorA.J. Sacks - Chief - Staff & Director - Corporate DevelopmentConference Call ParticipantsEric Schmidt - Biotechnology AnalystEric SchmidtOkay, good morning everyone and welcome back to day one of the Cantor conference. My name is Eric Schmidt, I'm one of the biotechnology analysts with the firm and it's my distinct pleasure to welcome our next presenting company for a fireside chat. ...